Our Approach
Not just a better cancer treatment — a totally novel approach to the treatment of blood cancers
We aim to shield the healthy cells, attack the cancer.
The Opportunity
Every year, thousands of patients with AML/MDS relapse post-transplant with no safe and effective treatment options. Vor Bio’s approach of shielded transplants provides the first opportunity to deliver potentially curative treatments post-transplant.
The Concept
Vor Bio is developing a novel blood cancer treatment approach—a shielded stem cell transplant that is designed to enable multiple modalities and therapies, including ADCs and CAR-Ts, which by themselves are highly toxic.
The Science
Vor Bio is developing a proprietary platform built on HSC biology, genome engineering, and CAR-T cells that has the potential to shield healthy cells from targeted therapies.
Programs
Our platform is driving multiple research programs in our pipeline for the possibility of a cure for Acute Myeloid Leukemia and other blood cancers.
Manufacturing
We are investing in our own manufacturing facilities and have designed a highly efficient process for clinical manufacturing of our shielded transplant and CAR-T cell therapy investigational products.
Partnerships
Our vision of a cure for blood cancers is only possible with the collaborative efforts of first-class external partners.